Surgical Resection
Treatment for Liver cancer due to alcohol use
Effectiveness
85%
Safety Score
25%
Clinical Trials
300
Participants
30K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
25
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate tumor removal, long-term survival
Treatment Duration
Single surgery, long recovery and follow-up
Evidence Quality
MODERATENumber Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$60,000
Side Effect Mgmt:$10,000
Total Annual:$76,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATEICER
$100,000/QALY
QALYs Gained
3
Outcome-Based Costs
Cost per Responder
$76,000
Cost per Remission
$126,667
Comparison vs Radiofrequency Ablation
Cost Difference
+$50,000/year
More expensive
QALY Difference
+0.10 QALYs
Better outcomes
Dominance
No dominance
Surgical Resection Outcomes
for Liver cancer due to alcohol use
Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+100%
Remission Rate
+60%
Common Side Effects
Postoperative bleeding
+10%
Infection
+15%
Bile leak
+5%
Liver failure
+3%
Prolonged hospital stay
+15%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov